Search Articles

Home / Articles

ACUTE LIMB ISCHEMIA IN COVID-19 PATIENTS WITH DELTA VARIANT IN INDIA: COHORT STUDY

. Dr. Ullas Bisleri , Dr. Vidya N R , Dr. Mahendra Kumar R and Ms. Reenal R Naik


Abstract

The aim of our study was to determine the incidence, characteristics, and clinical outcomes of patients with the novel coronavirus (COVID-19) infection who had presented with and been treated for acute limb ischemia (ALI) during the 2021 coronavirus pandemic.

Methods: A single-center observational cohort research was conducted. A prospectively maintained database was used to gather data from all patients who tested positive for COVID-19 and presented with ALI necessitating urgent surgical therapy. All patients were classified according to Rutherford classification for acute limb ischemia. The Data is subjected to statistical analysis to find the association and P<0.05 was considered significant.

Results: Evaluation of 15 patients who tested positive for Covid-19 with ALI was included in the study. The study results demonstrated that the Mean age of the patients was 51.2±10.7. The hypercoagulability condition was seen in both younger and older patients in our collection, with a male predominance (79.90%). In 12 individuals, surgical therapy was conducted (80%). The patients who had died were significantly younger (40 ± 10). It was noted that there is significant influence of Covid-19 illness on the ALI. Revascularization was successful in 12 of the 15 (80.1%).

Conclusion: According to our preliminary results, the prevalence of ALI has grown dramatically in India during delta variant of COVID-19 pandemic. Revascularization success was lower than predicted, which we attributed to a virus-induced hypercoagulable condition.

 

Index Terms- SARS-CoV-2 infection; acute limb ischemia; amputation ;

Download :